{
    "organizations": [],
    "uuid": "69b01b97bd30be9bdaf415c220f4fc05c40c9560",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-beats-q1-expectations/brief-novo-nordisk-beats-q1-expectations-lifts-2018-guidance-a-tad-idUSASO00043U",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk Beats Q1 Expectations; Lifts 2018 Guidance A Tad",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - NOVO NORDISK A/S SAYS:\n* OPERATING PROFIT DECREASED BY 8% IN DANISH KRONER AND INCREASED BY 6% IN LOCAL CURRENCIES IN THE FIRST THREE MONTHS OF 2018\n* 2018 OPERATING PROFIT GROWTH IS NOW EXPECTED TO BE 2-5% COMPARED WITH PRIOR GUIDANCE OF 1-5%\n* Q1 EBIT 12.4 BILLION DKK VERSUS 11.8 BILLION DKK SEEN IN REUTERS POLL\n* Q1 SALES 26.9 BILLION DKK VERSUS 26.7 BILLION DKK SEEN IN REUTERS POLL\n* 2018 SALES GROWTH IS NOW EXPECTED TO BE 3-5% MEASURED IN LOCAL CURRENCIES COMPARED WITH PRIOR GUIDANCE OF 2-5%\n* Q1 NET PROFIT 10.8 BILLION DKK VERSUS 10.1 BILLION DKK SEEN IN REUTERS POLL\n* 2018 SALES GROWTH AND OPERATING PROFIT GROWTH REPORTED IN DANISH KRONER ARE NOW EXPECTED TO BE 6 AND 9 PERCENTAGE POINTS LOWER THAN IN LOCAL CURRENCIES, RESPECTIVELY\n* CEO SAYS “BASED ON PERFORMANCE OF OUR KEY PRODUCTS VICTOZA, TRESIBA AND SAXENDA, WE DELIVERED SOLID UNDERLYING GROWTH IN BOTH SALES AND OPERATING PROFIT IN FIRST THREE MONTHS OF 2018”\n* EXPECTS SALES IN 2019 TO BE NEGATIVELY IMPACTED BY 1-2% AS A RESULT OF NEW REQUIREMENTS FOR MEDICARE PART D COVERAGE SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)\n ",
    "published": "2018-05-02T13:43:00.000+03:00",
    "crawled": "2018-05-03T12:17:03.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "novo",
        "nordisk",
        "say",
        "operating",
        "profit",
        "decreased",
        "danish",
        "krone",
        "increased",
        "local",
        "currency",
        "first",
        "three",
        "month",
        "operating",
        "profit",
        "growth",
        "expected",
        "compared",
        "prior",
        "guidance",
        "q1",
        "ebit",
        "billion",
        "dkk",
        "versus",
        "billion",
        "dkk",
        "seen",
        "reuters",
        "poll",
        "q1",
        "sale",
        "billion",
        "dkk",
        "versus",
        "billion",
        "dkk",
        "seen",
        "reuters",
        "poll",
        "sale",
        "growth",
        "expected",
        "measured",
        "local",
        "currency",
        "compared",
        "prior",
        "guidance",
        "q1",
        "net",
        "profit",
        "billion",
        "dkk",
        "versus",
        "billion",
        "dkk",
        "seen",
        "reuters",
        "poll",
        "sale",
        "growth",
        "operating",
        "profit",
        "growth",
        "reported",
        "danish",
        "krone",
        "expected",
        "percentage",
        "point",
        "lower",
        "local",
        "currency",
        "respectively",
        "ceo",
        "say",
        "based",
        "performance",
        "key",
        "product",
        "victoza",
        "tresiba",
        "saxenda",
        "delivered",
        "solid",
        "underlying",
        "growth",
        "sale",
        "operating",
        "profit",
        "first",
        "three",
        "month",
        "expects",
        "sale",
        "negatively",
        "impacted",
        "result",
        "new",
        "requirement",
        "medicare",
        "part",
        "coverage",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "jacob"
    ]
}